Recast 5 mg (Chewable Tablet)

Unit Price: ৳ 8.00 (30's pack: ৳ 240.00)

Medicine Details

Category Details
Generic Montelukast sodium
Company Monicopharma ltd
Also available as
Recast 10 mg tablet Recast 4 mg chewable tablet

Title

  • Recast 5 mg Chewable Tablet

Categories

  • Medicine
  • Pharmacology
  • Healthcare
  • Asthma Treatment
  • Allergic Rhinitis Treatment

Description

  • Recast is indicated for prophylaxis and chronic treatment of asthma
  • Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
  • Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
  • Selective and orally active leukotriene receptor antagonist
  • Inhibition of cysteinyl leukotriene receptor (CysLT1)
  • Selective blockage of leukotrienes responsible for asthma & allergic rhinitis symptoms
  • Dosage for adults and adolescents 15 years and older: Montelukast 10 mg tablet once daily
  • Dosage for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
  • Dosage for pediatric patients 2 to 5 years of age: Montelukast 4 mg tablet once daily
  • Dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily
  • Pharmacokinetic profile similar in elderly and younger adults
  • No dosage adjustment required in patients with mild-to-moderate hepatic insufficiency
  • No dosage adjustment recommended in patients with renal insufficiency
  • Therapeutic class: Leukotriene receptor antagonists
  • Storage condition: Store in cool & dry place below 30°C, protect from light & moisture, keep out of reach of children
  • Molecular Formula: C35H36ClNO3S
  • Chemical Structure supported by image
  • Used for the treatment of asthma or allergic rhinitis
  • Chewable tablet form
  • Observe effects of medication 1-3 hours after administration
  • Effect lasts for an average duration of 24 hours
  • Can be taken with or without food as prescribed
  • Use during pregnancy should be avoided unless clearly needed
  • Not indicated for use in the reversal of bronchospasm in acute asthma attacks
  • Not to be used as monotherapy for the treatment and management of exercise-induced bronchospasm
  • Common side effects: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
  • Uncommon side effects: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
  • Rare side effects: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor

Related Brands